<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hicks HB</submitter><funding>Vertex Pharmaceuticals</funding><funding>Syngenta International</funding><funding>GlaxoSmithKline</funding><funding>University of Oxford</funding><funding>Biotechnology and Biological Sciences Research Council</funding><funding>Merck Sharp and Dohme</funding><pagination>9174-9178</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9791679</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(50)</volume><pubmed_abstract>The (&lt;i>E&lt;/i>/&lt;i>Z&lt;/i>)-ocellenynes are C&lt;sub>15&lt;/sub> dibrominated &lt;i>Laurencia&lt;/i> natural products whose structures have been subject to several reassignments on the basis of extensive NMR analysis, biosynthetic postulates, and DFT calculations. Herein, we report the synthesis of both (&lt;i>E&lt;/i>)- and (&lt;i>Z&lt;/i>)-ocellenyne, which, in combination with single crystal X-ray diffraction studies, allows their absolute configuration to be established and defines the configuration of the &lt;i>syn&lt;/i>-12,13-dibromide as being (&lt;i>S&lt;/i>, &lt;i>S&lt;/i>) in keeping with their proposed biogenesis from the (6&lt;i>S&lt;/i>, 7&lt;i>S&lt;/i>)-laurediols.</pubmed_abstract><journal>Organic letters</journal><pubmed_title>Total Synthesis and Structure Confirmation of (&lt;i>E&lt;/i>) and (&lt;i>Z&lt;/i>)-Ocellenyne.</pubmed_title><pmcid>PMC9791679</pmcid><funding_grant_id>BB/P504890/1</funding_grant_id><pubmed_authors>Brown DS</pubmed_authors><pubmed_authors>Sousa BA</pubmed_authors><pubmed_authors>Christensen KE</pubmed_authors><pubmed_authors>Hicks HB</pubmed_authors><pubmed_authors>Burton JW</pubmed_authors><pubmed_authors>Sam Chan HS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Total Synthesis and Structure Confirmation of (&lt;i>E&lt;/i>) and (&lt;i>Z&lt;/i>)-Ocellenyne.</name><description>The (&lt;i>E&lt;/i>/&lt;i>Z&lt;/i>)-ocellenynes are C&lt;sub>15&lt;/sub> dibrominated &lt;i>Laurencia&lt;/i> natural products whose structures have been subject to several reassignments on the basis of extensive NMR analysis, biosynthetic postulates, and DFT calculations. Herein, we report the synthesis of both (&lt;i>E&lt;/i>)- and (&lt;i>Z&lt;/i>)-ocellenyne, which, in combination with single crystal X-ray diffraction studies, allows their absolute configuration to be established and defines the configuration of the &lt;i>syn&lt;/i>-12,13-dibromide as being (&lt;i>S&lt;/i>, &lt;i>S&lt;/i>) in keeping with their proposed biogenesis from the (6&lt;i>S&lt;/i>, 7&lt;i>S&lt;/i>)-laurediols.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-05T08:46:59.489Z</modification><creation>2024-11-08T13:28:01.383Z</creation></dates><accession>S-EPMC9791679</accession><cross_references><pubmed>36508492</pubmed><doi>10.1021/acs.orglett.2c03524</doi></cross_references></HashMap>